Pediatric cardiomyopathies harbour significant phenotypic and genetic heterogeneity. Genetic testing is essential for the initial evaluation and the ongoing care of child and family, although challenges remain regarding its appropriate clinical implementation in minors. We here discuss the key role of genetic diagnosis in the clinical management of two patients.
Keywords: Cardiomyopathies; Cardiotoxicity; Cascade screening; Children; Genetic counselling; Genetics.
Copyright © 2021 Elsevier B.V. All rights reserved.